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The aim of this study was to determine the number and state of activity of cytolytic T 
lymphocytes (CTL) and their precursors (CTL-P) present in vivo during the early 
stages of viral infection. The local response to lethal infection with rabies virus was 
used as a model system that is not accessible to analysis by secondary activation in 
vitro. The local response to alloantigen served as a control. Experimental protocols 
were established that allow frequency estimates of in vivo antigen-triggered CTL-P. 
Data allow a distinction between CTL-P activated in vivo by alloantigen and viral 
antigen with respect to their different capacity to utilize T cell growth factors (inter- 
leukins). In vivo alloantigen-primed CTL-P generate, in vitro, an active effector 
progeny in the presence of interleukins of xenogeneic origin, whereas the majority of 
virus-specific CTL-P, in spite of considerable expansion in vivo, fail to generate CTL 
in vitro unless antigen is added. 
1 Introduction 
Cell-mediated immunity appears to play a role in host control 
of rabies virus infection. In mice, a cytolytic T cell (CTL) 
response is induced only by attenuated rabies virus strains, but 
not after infection with virulent strains causing lethal disease. 
Thus, the level of T cell response may predict the course of the 
murine infection [1-4]. Data reported so far were obtained in 
long-term (16-24-h) assays not directly comparable with data 
in the conventional 4-h assay and contain little quantitative 
information. In this report, the first frequency estimates of 
rabies-specific cytolytic T lymphocyte precursors (CTL-P) and 
their in vivo generated interleukin-sensitive progeny (IL-CTL- 
P )  are described in direct comparison with the corresponding 
frequencies observed in the response towards allogeneic major 
histocompatibility complex (MHC)-encoded antigens under 
4-h assay conditions. The determination of CTL-P frequency 
was carried out by different experimental protocols. The 
experiments were designed to obtain information on the activ- 
ity and frequency of cells triggered by antigen in vivo. There- 
fore, culture conditions were established that avoided the 
selective effects of secondary exposure of CTL-P to antigen in 
vitro. 
We find that even during a lethal rabies infection specifically 
sensitized T cells are present and can be expanded in vitro to 
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detectable cytolytic progeny in the presence of T cell growth 
factors (IL2). Interestingly, after in vivo sensitization by anti- 
gen, the majority of alloantigen-specific CTL-P are susceptible 
to the effect of IL2  in vitro, whereas most of the cells acti- 
vated by rabies virus need further stimulation by antigen in 
vitro to generate functionally active clones. It may be this 
deficiency or delay in maturation that limits the potential pro- 
tective role of cell-mediated immunity during a lethal rabies 
infection. 
2 Materials and methods 
2.1 Mice 
C57BL/6 (H-2b) and DBA/2 (H-2d) mice were purchased from 
the Zentralinstitut fur Versuchstiere, Hannover, FRG. Male 
mice were used at 4-6 weeks of age. 
2.2 In vivo priming for CTL effector cell responses 
C57BL/6 (H-2b) mice were primed by footpad injection of 
either 5 x lo6 mitomycin C-treated DBA/2 (H-2d) spleen cells 
(SC) or lo7 plaque-forming units (PFU) of gradient-purified 
tissue culture (BHK)-grown ERA strain of rabies virus 
(ERA). Mice were killed four days after antigen application. 
2.3 Microcultures 
The cells of the draining popliteal lymph nodes (LN) were 
suspended in RPMI 1640 medium (2 mM L-glutamine, 
5 X M 2-mercaptoethanol, 10% v/v fetal calf serum) and 
graded numbers in 36 replicateslconcentration were plated in 
96-well round-bottom microtiter plates (Greiner, Niirtingen, 
FRG). Incubation was performed under standard conditions 
(37"C, 5% C02,  humidified atmosphere) for 9 days in the 
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presence of mitomycin C-treated stimulator (5 x 10’ DBA/2 
SC, lo4 ERA-infected MC57G (H-Zb) fibrosarcoma cells) or 
filler cells (5 x lo5 C57BW6 SC, lo4 noninfected MC57G cells) 
depending on the protocol intended. ERA infection of cells 
was performed 24 h prior to use and efficiency of infection was 
controlled by direct immunofluorescence. Cultures were sup- 
plemented with 40% v/v IL2-containing supernatant obtained 
from concanavalin A (Con A)-activated rat SC. Suppressive 
factors in the supernatant were eliminated by 24 h dialysis 
against 0.9% saline in Spectrapor tubing (Roth, Karlsruhe, 
FRG; cutoff 12-14 kDa) and contaminating Con A was 
blocked by adjusting the supernatant to 100 mM methyl-a-D- 
mannopyranoside. 
2.4 Cytolytic assay and calculations 
After 9 days of in vitro incubation, the lytic activity of indi- 
vidual cultures was determined on lo3 ’kr-labeled (2-3 cpm/ 
cell) target cells in a conventional 4-h ’kr-release assay [5]. 
Target cells were ERA-infected MC57G fibrosarcoma cells 
and noninfected controls or, in the case of the alloresponse, 
DBMZderived P815 mastocytoma cells. Low controls were 
obtained by incubation of targets with cultures (36 replicates) 
containing stimulator or filler cells only, resulting in a release 
of 10-14% of total incorporated radioactivity. A culture was 
considered “responding” if the release exceeded the 99% 
tolerance limit of the low control normal distribution (but at 
least 5% specific lysis) and as “antigen-specific” if it was 
scored as negative on the control target. The proportion of 
nonresponding cultures was plotted on a logarithmic scale on 
the y axis against the cell input on a linear scale on the x axis. 
The best-fitting straight line through the origin was calculated 
by the least square method and goodness of fit tested by a x2 
test. Only if the single hit hypothesis could be accepted with a 
probability of p > 0.05 (range 0.25 < p < 0.9 in reported exper- 
iments) the relative CTL-P frequency was estimated according 
to the Poisson statistics. All calculations were carried out on a 
Commodore CBM 3032 computer using software mathemati- 
cally based on Lefkovits and Waldmann [6]. 
3 Results 
3.1 Direct CTL activity measurable after in vivo priming 
TO induce a lethal infection in C57BL/6 mice, an appropriate 
dose (lo7 PFU) of an attenuated but still virulent strain of 
rabies virus ERA was applied locally by injection into the hind 
footpad, causing death within 6 1 2  days post infection. On 
day 4 post infection the primary immune response in the 
popliteal LN draining the infected area was analyzed. This 
infection route is closer to the natural route than the nonlethal 
i.p. application. Early detection time was necessary to analyze 
the system in a state of activation and avoid interference by the 
onset of acute sickness. This 4-day in vivo local sensitization 
protocol should provide information on the cytolytic activity 
generated in vivo. 
Despite the evident immune reaction visible by an increase in 
the overall cell number from 5 x lo’ in the popliteal LN of an 
unprimed host to 4 x lo6 after antigen encounter, no signifi- 
cant rabies-specific cytotoxicity was detectable in the direct 4-h 
cell-mediated lysis assay. This failure however is not unique to 
rabies infection, but can also be observed when a similar pro- 
tocol is applied to study the in vivo reaction of C57BL/6 
popliteal LN cells towards a local DBAI2 lymphoid cell allo- 
graft, elicited by injecting 5 X lo6 mitomycin C-treated SC into 
the hind footpad. The definite but rather low response to 
alloantigen (18 f 2% specific lysis at an effectorharget ratio of 
40 : 1) is in line with earlier reports [7] and has been explained 
as the consequence of an in vivo operating type of suppressor 
cell contraacting the clonal expansion of sensitized pre-killer T 
cells [7, 81. 
3.2 Detection of CTL by limiting dilution techniques 
Cells of the CTL lineage may participate at different matura- 
tion stages in the acute primary immune response in vivo. To 
perform quantitative analysis we used three types of limiting 
Table 1. Comparison of anti-MHC (H-2d) with anti-ERA CTL-P/IL-CTL-P frequencies in C57BL/6 mouse popliteal LN cellsa) 
Pro- Antigen presentation Estimate of the relative Estimate of the 
tocol frequency absolute 
In vivo In vitro (95% confidence limits) frequency/LN 
1 Unprirned MHC-antigen + IL I /  179 (48004400)b’ 2400 - 3200 
2 MHC-antigen MHC-antigen + IL I/ 197 (38004400) 15ooO -26000 
3 MHC-antigen IL I/ 2% (27W-4200) 11O0o -17000 
1 Unprimed ERA + IL 1/277000 (1- 6) 0.5- 3 
2 ERA ERA + IL 1/ 16270 (52- 71) 208 - 284 
3 ERA IL 1/ 60990 (14- 19) 56 - 76 
Four to 6-week-old male (C57BW6 (H-2b) mice were primed by footpad injection of either 5 X lo6 mitomycin C-treated DBA/2 (H-2d) SC or 
lo7 PFU of purified tissue culture (BHK)-grown ERA-strain of rabies virus. Four days later the cells of the draining popliteal LN were 
suspended in IL-containing medium and seeded under limiting dilution conditions in microtiter plates. After a 9-day culture in the presence 
or absence of antigen, the cytolytic activity of individual cultures was determined in a T r  release assay. Target cells were either ERA- 
infected MC57G fibrosarcoma cells and noninfected controls for virus-specific CTL or DBA/2 derived P815 mastocytoma cells to test the 
alloreactive CTL. The frequency calculations were performed as described in Sect. 2.4. The estimate of the absolute frequency was 
calculated by correcting the relative frequency for the mean number of cells per LN: 5 x lo5 (measured for a pool of 20 LN) in unprimed 
animals and 4 x 106 (pool of 8 LN) in alloantigen-primed or ERA-primed animals. 
Per lo6. 
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dilution protocols. The first protocol is identical with the con- 
ventional limiting dilution assay widely used to determine the 
frequencies of CTL-P that represent the primary repertoire in 
the lymphoid organs of a noncommitted animal [6, 91. To 
determine these frequencies popliteal LN cells of unprimed 
C57BL/6 mice were cultured for 9 days under limiting dilution 
conditions in the continuous presence of antigen-presenting 
stimulator cells (allogeneic DBA/2 SC or rabies-infected 
MC57G fibrosarcoma cells). To ensure that the CTL-P repre- 
sented the only limiting cell type, external help was provided 
by ILZcontaining medium [lo-121. The response of C57BL/6 
popliteal LN cells to allogeneic D B N 2  SC was used as control 
to monitor the quality of the in vitro technique applied and 
permit comparison with published data. The results obtained 
are given in Table 1. In several repeated experiments the fre- 
quency of alloantigen-reactive CTL-P varied between 1/100- 
1/1000 cells. This is in line with experiments carried out by 
others [12-151 and shows the extreme deviation from the fre- 
quency of rabies-specific CTL-P (0.5-3 precursor cells/total 
popliteal LN) which was determined in several independent 
experiments (see Fig. lc). 
Figure 1. (a) Data already contained in Table 1 are depicted. 
Popliteal LN cells from C57BL/6 mice infected 4 days earlier with 
ERA rabies virus were plated in 36 replicates per concentration under 
restimulation (protocol 2; 6 0 )  or expansion (protocol 3; -0) 
conditions. The mode of calculation is explained in Sect. 2.4. The 
shaded areas represent the 95% confidence intervals for the slopes of 
the regression lines. 
(b) To show the specificity of CTL obtained after in vivo priming 
followed by in vitro IL-mediated expansion (protocol 3), one experi- 
mental point of the limiting dilution analysis (indicated by the arrow in 
Fig. la) is resolved to greater detail. The four-fold split cultures were 
assayed on lo3 ERA-infected target cells and noninfected controls in 
presence or absence of 4 X lo3 nonlabeled noninfected competitor 
cells. Lytic activity on targets in the presence of competitor cells is 
depicted on the x axis and lytic activity in absence of competitor cells, 
on the y axis. The dashed lines represent the tolerance limits of the low 
controls. Specific lysis was seen only on ERA-infected target cells, 
independent of the presence or absence of noninfected competitor 
cells (comparison A+ B; 0). Activity on noninfected target cells was 
negligible (comparison C+D; 0). It was found in separate experi- 
ments that after addition of 4 X lo' competitor cells carrying the viral 
antigens to responding cultures no cytolytic activity on labeled 
infected target cells was seen (data not shown). 
(c) Frequency and specificity analysis of the primary in vitro-activated 
anti-ERA CTL (compare Table 1, protocol I). Specificity of effector 
cells from one responder concentration (8 X 104/well, 36 replicates, 
arrow in upper part of the figure) is demonstrated in the correlation 
plot. The split control (comparison A+ B; 0) confirms that a culture 
scored as positive on the infected target cells remained positive in a 
second determination. The same cultures were scored as negative on 
the noninfected target cells (comparison A+ C; 0). For the sake of 
clarity, double negative cultures are not included. 
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The second protocol combines the short-term (4-day) in vivo 
local antigen presentation described above with the in vitro 
technique of the first protocol. Thus, in vivo antigen-sensitized 
and pre-expanded cells were subjected to further IL-mediated 
expansion in vitro. In addition, restimulation by exposure to 
antigen in vitro may activate those precursors that have not yet 
acquired sensitivity to IL, as well as those in vivo generated 
mature CTL that may have already lost this reactivity. For 
these reasons, we expect to find the maximal frequencies fol- 
lowing this protocol. Results are depicted in Table 1 and in 
Fig. la. In the alloresponse, the relative frequency remains 
constant after priming, but taking into account the change in 
the overall cell number a ten-fold increase in the absolute 
frequency was found. In the rabies system this increase is 
hundred-fold and the corresponding relative frequency of 
52-71/106 cells is similar to that found after myxo- and para- 
myxovirus infection of mice ([16, 171; B. Askonas, personal 
communication). However, there is one important difference 
between frequency estimates during acute virus infection and 
those after recovery from disease: published experiments on 
antiviral CTL-P frequencies were usually carried out by reac- 
tivating memory cells following long-term priming; however, 
in our short-term priming protocol, we assumed the antigen- 
specific sensitized cells were in a state of activation. Conse- 
quently, a similar frequency should be obtained by just 
expanding these cells in the presence of IL devoid of addi- 
tional antigen. 
The third protocol provides an approach to determine the fre- 
quencies of IL-sensitive CTL-P that reflect acute activation 
during an immune response in vivo. The experimental proce- 
dure was based on the widely-accepted concept that antigenic 
triggering induces differentiation of IL 2-insensitive CTL-P to 
IL-CTL-P which can be further propagated solely by the 
action of IL [11, 181. This concept, valid so far under in vitro 
conditions, is now strongly confirmed by our observation that 
acquisition of IL responsiveness in vivo and propagation in 
vitro can be separated (Table 1 and Fig. la). The frequency of 
in vivo activated alloantigen-specific IL-CTL-P found after IL- 
mediated expansion is not significantly different than the fre- 
quency obtained after additional antigen restimulation. There- 
fore it was concluded that most of the alloantigen-activated 
CTL-P mature to IL-CTL-P in vivo, whereas most of the in 
vivo ERA-sensitized CTL-P fail to mature to detectable IL- 
CTL-P in vivo but generate an active effector progeny after 
additional antigen exposure in vitro (Fig, la). The cytolytic 
activity is specific for virus-infected cells (Fig. 1b). 
An explanation for the observed difference could be that con- 
taminating antigen may provide variable restimulation condi- 
tions. However, ERA virus does not infect resting or activated 
lymphoid cells (unpublished observations) and neither viral 
antigens [19] nor cells carrying graft alloantigen [7] are detect- 
able in the draining LN 3-4 days after priming. 
4 Discussion 
It has been shown that rabies-specific CTL-P present in low 
numbers in the noncommitted host become sensitized and con- 
siderably expand in vivo, even in the course of a lethal infec- 
tion. Thus, cell-mediated immunity is part of the antiviral 
defense mechanism, but evidently does not provide successful 
protection. This may be due to the low absolute numbers of 
participating cells compared with the reaction against foreign 
H-2 antigens. In addition, our data suggest that the in vivo 
process of maturation is essentially different in the two types 
of antigens investigated. Alloantigen- and rabies-specific IL- 
CTL-P may have acquired different IL sensitivity profiles at a 
given time after priming. A delay in the maturation of rabies- 
specific CTL seems reasonable considering the fact that 
alloantigen is already presented in association with cell sur- 
faces, whereas free live virus has to achieve in vivo the approp- 
riate presentation necessary for H-2-restricted recognition 
[20]. The extent of presentation may also vary in rabies strains 
of different virulence depending on their ability to proliferate 
at the site of infection. The immunosuppressive effect 
described for lethal infections with street rabies virus [21] may, 
in addition, inhibit the further in vivo maturation of sensitized 
CTL-P. To investigate these possibilities in detail and define 
whether the alloantigen or the rabies virus type of in vivo 
CTL-P activation reflects the normal pathway, other viruses, 
in particular rabies strains of different virulence, need to be 
tested. 
Our results have a general implication in addition to their 
virological aspects. It was found that the majority of in vivo 
antigen-triggered and considerably expanded antiviral CTL-P 
cannot utilize IL2. The generation of functionally active prog- 
eny is seen only in presence of antigen in vitro. One important 
question is whether these CTL-P themselves need further 
direct contact with cells carrying antigen or whether regulatory 
mechanisms are activated, resulting in direct or soluble helper 
effects that cannot be provided by IL 2 of xenogeneic origin. 
The inability of CTL-P to utilize the nonspecific help provided 
by IL2 has been reported by Plate [22 ] .  She describes that 
during early stages of syngeneic H-2-restricted (but not 
allogeneic) responses the CTL-P need additional MHC- 
restricted help provided by Ia' T cells in the in vitro system. 
Our data are compatible with the explanation that during the 
early stages of activation the majority of CTL-P require MHC- 
restricted soluble help that is not provided in the absence of 
antigen. Further analysis is required to explore this possibility. 
The increase in frequency observed after local priming indi- 
cates a considerable expansion of CTL-P even during a pri- 
mary response. Thus the postulated suppressive mechanism 
mentioned above [7, 8) may limit, but evidently does not pre- 
vent, in vivo proliferation. According to Teh et al. [14] a 
minimum clone size of 40 CTL is necessary to detect signifi- 
cant lysis on 300 target cells. Based on our estimate of about 
11300 alloantigen-specific in vivo generated IL-CTL-P 
(Table 1) we expected the detection threshold of the direct 
cell-mediated lysis assay to be at an effectorharget ratio of 
40 x 300 : 300 = 40 : 1. In fact, significant lysis was observed at 
this ratio and there is no need to postulate suppressive mecha- 
nisms to explain a low direct activity. The corresponding esti- 
mate for ERA-specific direct cytotoxicity predicts the 
threshold will be at an effectorkarget ratio of 40 x 60 000 : 300 
= 8000 : 1 and explains why CTL are not detectable in a direct 
4-h assay. The operationally defined TL-CTL-P comprise IL- 
reactive cells of the CTL lineage, regardless of their capacity 
for effector function. Based on our calculations, we do not 
exclude the possibility that we are dealing with in vivo gener- 
ated mature CTL rather than with CTL-P. In any case, we feel 
that the frequencies measured following protocol 3 represent 
the closest available approximation to the frequencies of CTL 
present in vivo. 
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A comparison of two anti-neuraminidase monoclonal 
antibodies by complement activation* 
The specificities of two anti-neuraminidase monoclonal antibodies have been com- 
pared by their ability to fix complement. They were found to differ to some extent in 
their reactivity with a range of N2 influenza viruses. Thus, as in the case of anti- 
hemagglutinin antibodies, anti-neuraminidase monoclonal antibodies are able to 
detect subtle structural changes in the viral antigen. Although both monoclonal anti- 
bodies fixed complement with intact virus, neither one fixed complement when corn- 
plexed with isolated neuraminidase “heads”. 
1 Introduction 
The type A viruses of influenza are characterized by their 
ability to alter the antigenic character of their two surface 
glycoproteins, hemagglutinin and neuraminidase (Nase) [ 11. 
Two kinds of antigenic variations occur; antigenic drift, which 
involves gradual changes in surface antigens, and antigenic 
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shift, which is a sudden and complete change in one or both of 
the surface antigens resulting in the emergence of a new virus. 
Although antigenic drift occurs randomly, it is thought that the 
presence of antibody in an immune population selects viruses 
with altered antigenic determinants which have an advantage 
in the presence of antibody. The means by which anti-hemag- 
glutinin antibodies neutralize the virus appears to be preven- 
tion of the virion binding to the host cell [2]. 
Anti-Nase antibodies are less effective than anti-hemaggluti- 
nin antibodies in neutralizing the virus in vitro [3] and normal 
titers in vivo do not confer complete protection against infec- 
tion [4, 51. High titers of this antibody have been found, how- 
ever, in patients witch immunity to influenza [6]. 
The Nase of human influenza has changed dramatically only 
once since influenza viruses have been studied. This was in 
1957 when the H2N2 strain appeared, replacing viruses with 
the N1 Nase. There is evidence that this enzyme is needed for 
both initial viral penetration [2] and for the release of newly 
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